Literature DB >> 8077794

Evaluation of cardiovascular risk factors in overweight and obese subjects.

G Avellone1, V Di Garbo, R Cordova, G Cucinella, R De Simone, G Raneli, G Bompiani.   

Abstract

Twenty obese subjects (Males = 8, Females = 12; average age = 39.5 +/- 2.5 years; B.M.I. = 36.2 +/- 2.5), 20 overweight subjects (Males = 8, Females = 12; average age = 38.5 +/- 2 years; B.M.I. = 28.8 +/- 0.4) and 20 non obese healthy subjects as controls, matched for sex and age (Males = 8, Females = 12; average age = 37.5 +/- 2 years; B.M.I. = 22.4 +/- 0.8) were selected. We determined: blood glucose, triglycerides, total cholesterol, HDL-cholesterol, Apolipoproteins A1 and B, Factor VII, fibrinogen and plasminogen. Before and after a venous occlusion test were also measured: t-PA Antigen, PAI activity and haematocrit. Metabolic, coagulative and fibrinolytic pathological changes were observed in overweight and obese subjects and the interaction of these risk factors may contribute to the pathogenesis of atherosclerosis vascular disease and to the high rate of thromboembolic events reported in obesity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077794

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  3 in total

Review 1.  Obesity and inflammation: a new look at an old problem.

Authors:  Sachin Mehta; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

2.  Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.

Authors:  Marie-Thérèse Berthier; Alain Houde; Jean Bergeron; Denis Prud'homme; Jean-Pierre Després; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-07-08       Impact factor: 3.172

3.  Arm Circumference-to-Height Ratio as a Situational Alternative to BMI Percentile in Assessing Obesity and Cardiometabolic Risk in Adolescents.

Authors:  Wasantha Jayawardene; Stephanie Dickinson; David Lohrmann; Jon Agley
Journal:  J Obes       Date:  2018-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.